Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Apr 30, 2025
Trial Information
Current as of November 07, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study, called AI-VT, is testing whether adding non-invasive computer analysis of heart electrical signals and CT images can help guide the ablation procedure that treats ventricular tachycardia (a fast heartbeat starting from the heart’s lower chambers). It’s an interventional, single-group study at UC San Diego Health. Participants will have VT ablation with this extra computational mapping in addition to standard care, with the goal of more accurately locating the problem area.
Who may be eligible? Adults roughly 21 to 90 years old who have ventricular tachycardia documented on an ECG, during monitoring, or by their heart device. About 250 people may enroll, and the study is currently enrolling by invitation. If you participate, researchers will track whether VT recurs and overall survival over the first year, along with safety outcomes such as short-term changes in blood pressure or heart function, possible stroke, bleeding or vascular problems, and the need for ICU care. The study has safety oversight and uses data under strict privacy rules, with the aim of learning whether this imaging-guided approach can improve results beyond the standard VT ablation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age between 21 and 100
- • 2. Evidence of ventricular tachycardia on ECG, telemetry or by CIED interrogation.
- Exclusion Criteria:
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Jolla, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported